Cargando…

Evaluating Mobile Apps and Biosensing Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms or Chronic Obstructive Pulmonary Disease: Protocol for a Proof-of-Concept, Open-Label, Feasibility Study

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a global public health problem, and continuous monitoring is essential for both its management as well as the management of other chronic diseases. Telemonitoring using mobile health (mHealth) devices has the potential to promote self-manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharman, Almaz, Zhussupov, Baurzhan, Sharman, Dana, Kim, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146253/
https://www.ncbi.nlm.nih.gov/pubmed/32213479
http://dx.doi.org/10.2196/16461
_version_ 1783520158324621312
author Sharman, Almaz
Zhussupov, Baurzhan
Sharman, Dana
Kim, Irina
author_facet Sharman, Almaz
Zhussupov, Baurzhan
Sharman, Dana
Kim, Irina
author_sort Sharman, Almaz
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a global public health problem, and continuous monitoring is essential for both its management as well as the management of other chronic diseases. Telemonitoring using mobile health (mHealth) devices has the potential to promote self-management, improve control, increase quality of life, and prevent hospital admissions. OBJECTIVE: This study aims to demonstrate whether a large-scale study assessing the use of mHealth devices to improve the treatment, assessment, compliance, and outcomes of chronic diseases, particularly COPD and cardio-metabolic syndrome, is feasible. This will allow our team to select the appropriate design and characteristics for our large-scale study. METHODS: A total of 3 cohorts, with 9 participants in each, will use mHealth devices for 90 days while undergoing the current standard of care. These groups are: 9 “non-COPD,” otherwise healthy, smokers; 9 “grey zone” smokers (forced expiratory volume in 1 second/ forced vital capacity ≥0.70 after bronchodilator treatment; COPD Assessment Test ≥10); and 9 smokers diagnosed with Stage 1-3 COPD. Rates of recruitment, retention, and adherence will be measured. Overall, two mHealth devices will be utilized in the study: the AnaMed Original Equipment Manufacturer device (measures distance, energy expenditure, heart rate, and heart rate variability) and the Air Next mobile spirometry device. The mHealth devices will be compared against industry standards. Additionally, a questionnaire will be administered to assess the participants’ perceptions of the mHealth technologies used. RESULTS: The inclusion of participants started in June 2019. Study results will be published in peer-reviewed scientific journals. CONCLUSIONS: This study will demonstrate whether a large-scale study to assess the use of mHealth devices to improve the treatment, assessment, compliance, and outcomes of chronic diseases, particularly COPD and cardio-metabolic syndrome, is feasible. It will also allow the research team to select the appropriate design and characteristics for the large-scale study. TRIAL REGISTRATION: ClinicalTrials.gov NCT04081961; https://clinicaltrials.gov/ct2/show/NCT04081961 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/16461
format Online
Article
Text
id pubmed-7146253
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-71462532020-04-21 Evaluating Mobile Apps and Biosensing Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms or Chronic Obstructive Pulmonary Disease: Protocol for a Proof-of-Concept, Open-Label, Feasibility Study Sharman, Almaz Zhussupov, Baurzhan Sharman, Dana Kim, Irina JMIR Res Protoc Protocol BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a global public health problem, and continuous monitoring is essential for both its management as well as the management of other chronic diseases. Telemonitoring using mobile health (mHealth) devices has the potential to promote self-management, improve control, increase quality of life, and prevent hospital admissions. OBJECTIVE: This study aims to demonstrate whether a large-scale study assessing the use of mHealth devices to improve the treatment, assessment, compliance, and outcomes of chronic diseases, particularly COPD and cardio-metabolic syndrome, is feasible. This will allow our team to select the appropriate design and characteristics for our large-scale study. METHODS: A total of 3 cohorts, with 9 participants in each, will use mHealth devices for 90 days while undergoing the current standard of care. These groups are: 9 “non-COPD,” otherwise healthy, smokers; 9 “grey zone” smokers (forced expiratory volume in 1 second/ forced vital capacity ≥0.70 after bronchodilator treatment; COPD Assessment Test ≥10); and 9 smokers diagnosed with Stage 1-3 COPD. Rates of recruitment, retention, and adherence will be measured. Overall, two mHealth devices will be utilized in the study: the AnaMed Original Equipment Manufacturer device (measures distance, energy expenditure, heart rate, and heart rate variability) and the Air Next mobile spirometry device. The mHealth devices will be compared against industry standards. Additionally, a questionnaire will be administered to assess the participants’ perceptions of the mHealth technologies used. RESULTS: The inclusion of participants started in June 2019. Study results will be published in peer-reviewed scientific journals. CONCLUSIONS: This study will demonstrate whether a large-scale study to assess the use of mHealth devices to improve the treatment, assessment, compliance, and outcomes of chronic diseases, particularly COPD and cardio-metabolic syndrome, is feasible. It will also allow the research team to select the appropriate design and characteristics for the large-scale study. TRIAL REGISTRATION: ClinicalTrials.gov NCT04081961; https://clinicaltrials.gov/ct2/show/NCT04081961 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/16461 JMIR Publications 2020-03-26 /pmc/articles/PMC7146253/ /pubmed/32213479 http://dx.doi.org/10.2196/16461 Text en ©Almaz Sharman, Baurzhan Zhussupov, Dana Sharman, Irina Kim. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 26.03.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Sharman, Almaz
Zhussupov, Baurzhan
Sharman, Dana
Kim, Irina
Evaluating Mobile Apps and Biosensing Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms or Chronic Obstructive Pulmonary Disease: Protocol for a Proof-of-Concept, Open-Label, Feasibility Study
title Evaluating Mobile Apps and Biosensing Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms or Chronic Obstructive Pulmonary Disease: Protocol for a Proof-of-Concept, Open-Label, Feasibility Study
title_full Evaluating Mobile Apps and Biosensing Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms or Chronic Obstructive Pulmonary Disease: Protocol for a Proof-of-Concept, Open-Label, Feasibility Study
title_fullStr Evaluating Mobile Apps and Biosensing Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms or Chronic Obstructive Pulmonary Disease: Protocol for a Proof-of-Concept, Open-Label, Feasibility Study
title_full_unstemmed Evaluating Mobile Apps and Biosensing Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms or Chronic Obstructive Pulmonary Disease: Protocol for a Proof-of-Concept, Open-Label, Feasibility Study
title_short Evaluating Mobile Apps and Biosensing Devices to Monitor Physical Activity and Respiratory Function in Smokers With and Without Respiratory Symptoms or Chronic Obstructive Pulmonary Disease: Protocol for a Proof-of-Concept, Open-Label, Feasibility Study
title_sort evaluating mobile apps and biosensing devices to monitor physical activity and respiratory function in smokers with and without respiratory symptoms or chronic obstructive pulmonary disease: protocol for a proof-of-concept, open-label, feasibility study
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146253/
https://www.ncbi.nlm.nih.gov/pubmed/32213479
http://dx.doi.org/10.2196/16461
work_keys_str_mv AT sharmanalmaz evaluatingmobileappsandbiosensingdevicestomonitorphysicalactivityandrespiratoryfunctioninsmokerswithandwithoutrespiratorysymptomsorchronicobstructivepulmonarydiseaseprotocolforaproofofconceptopenlabelfeasibilitystudy
AT zhussupovbaurzhan evaluatingmobileappsandbiosensingdevicestomonitorphysicalactivityandrespiratoryfunctioninsmokerswithandwithoutrespiratorysymptomsorchronicobstructivepulmonarydiseaseprotocolforaproofofconceptopenlabelfeasibilitystudy
AT sharmandana evaluatingmobileappsandbiosensingdevicestomonitorphysicalactivityandrespiratoryfunctioninsmokerswithandwithoutrespiratorysymptomsorchronicobstructivepulmonarydiseaseprotocolforaproofofconceptopenlabelfeasibilitystudy
AT kimirina evaluatingmobileappsandbiosensingdevicestomonitorphysicalactivityandrespiratoryfunctioninsmokerswithandwithoutrespiratorysymptomsorchronicobstructivepulmonarydiseaseprotocolforaproofofconceptopenlabelfeasibilitystudy